I doubt much money is spent on Daraprim overall. $75k is apparently the overall cost of a course of treatment to insurers, in addition to the two or three other

I doubt much money is spent on Daraprim overall. $75k is apparently the overall cost of a course of treatment to insurers, in addition to the two or three other drugs prescribed to reduce the side effects of the drug. It is apparently not in common use, Health Canada says that hospitals simply don't buy it anymore as of 2013, well before the price increase. I suspect that if there's an entire first-world nation which no longer purchases the drug in hospitals or pharmacies, sales volume is probably pretty low in the U.S. I don't see what kind of premium increase you could attribute to that.